PSA pooh-poohed
This article was originally published in The Gray Sheet
Executive Summary
A task force sponsored by the Agency for Healthcare Research and Quality recommended that men 75 years or older should not undergo routine screening for prostate-specific antigen. The U.S. Preventative Services Task Force said Aug. 4 that it found "adequate evidence that the incremental benefits of treatment for prostate cancer detected by screening are small to none" for this population. For younger men, there was inadequate evidence to conclude whether or not routine PSA screening improved health outcomes